A. Sasaki

发表

Long‐term observation of reflux oesophagitis developing after Helicobacter pylori eradication therapy

K. Chayama, K. Haruma, S. Tanaka, 2003, Alimentary pharmacology & therapeutics.

Clinical characteristics and natural history of patients with low‐grade reflux esophagitis

K. Chayama, K. Haruma, N. Manabe, 2002, Journal of gastroenterology and hepatology.

Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells.

K. Chayama, K. Haruma, N. Oue, 2003, Biochemical and biophysical research communications.

Basis of Decreased Risk of Gastric Cancer in Severe Atrophic Gastritis with Eradication of Helicobacter pylori

K. Chayama, Y. Kitadai, M. Sumii, 2006, Digestive Diseases and Sciences.

Mucin Phenotype and Background Mucosa of Intramucosal Differentiated-Type Adenocarcinoma of the Stomach

K. Chayama, K. Haruma, Shinji Tanaka, 2004, Oncology.

Serological comparison of serum pepsinogen and anti-parietal cell antibody levels between Japanese and German patients

K. Chayama, K. Haruma, Shinji Tanaka, 2002, European journal of gastroenterology & hepatology.

Role of Anti-Parietal Cell Antibody in Helicobacter pylori -associated Atrophic Gastritis: Evaluation in a Country of High Prevalence of Atrophic Gastritis

K. Chayama, K. Haruma, S. Tanaka, 2002, Scandinavian journal of gastroenterology.

Helicobacter pylori Infection Influences Tumor Growth of Human Gastric Carcinomas

K. Chayama, K. Haruma, S. Tanaka, 2003, Scandinavian journal of gastroenterology.

The long‐term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis

K. Haruma, H. Kusunoki, J. Hata, 2003, Alimentary pharmacology & therapeutics.

Endoscopic findings of the gastric mucosa during long-term use of proton pump inhibitor – a multicenter study

K. Chayama, Shinji Tanaka, M. Yoshihara, 2017, Scandinavian journal of gastroenterology.